Expert Guidance on the Overall Management of Liver Cancer During the COVID-19 Pandemic

The COVID-19 pandemic remains complex, with concentrated and sporadic cases in multiple locations. During COVID-19 outbreaks, the routine diagnosis and treatment of liver cancer patients can be affected to a significant degree. For liver oncologists, it is important to identify strategies and protocols to reduce the risk of COVID-19 infection among patients and medical staff, use limited medical resources to maximally ensure access to anti-tumor treatment and related emergency treatment, and provide support for patients during the disruption caused by the pandemic. Given this requirement, eleven experts in liver cancer treatment-related disciplines from Zhongshan Hospital, Fudan University have written the Expert Guidance on the Overall Management of Liver Cancer During the COVID-19 Pandemic, which aims to provide a reference to assist liver oncologists in conducting clinical work safely and effectively while implementing COVID-19 prevention and control strategies and offer guidance on supporting liver cancer patients during the pandemic.